The role of disturbed pH dynamics and the NA+/H+ exchanger in metastasis

Nature Reviews Cancer

Volumn 5, Issue 10, 2005, Pages 786-795

  Cardone, Rosa A ^a   Casavola, Valeria ^a   Reshkin, Stephan J ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COTRANSPORTER; HYDROGEN LACTATE COTRANSPORTER; PROTEIN INHIBITOR; SODIUM PROTON EXCHANGE PROTEIN 1; UNCLASSIFIED DRUG;

ACIDIFICATION; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL MIGRATION; CELL STRUCTURE; CLINICAL TRIAL; HEART MUSCLE ISCHEMIA; HUMAN; METABOLISM; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW; TUMOR CELL;

ANIMALS; CATION TRANSPORT PROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; MEMBRANE PROTEINS; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER;

EID: 25844528025     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1713     Document Type: Review

References (77)

1. Gillies, R. J., Raghunand, N., Karczmar, G. S. & Bhujwalla, Z. M. MRI of the tumor microenvironment. J. Magn. Reson. Imaging 16, 430-450 (2002). A comprehensive review of the distribution, role and methods of measuring the metabolic microenvironment
2. Montcourrier, P., Silver, I., Farnoud, R., Bird, I. & Rochefort, H. Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism. Clin. Exp. Metastasis 15, 382-392 (1997).
3. Parkins, C. S., Stratford, M. R., Dennis, M. F., Stubbs, M. & Chaplin, D. J. The relationship between extracellular lactate and tumour pH in a murine tumour model of ischaemia-reperfusion. Br. J. Cancer 75, 319-323 (1997).
4. Madshus, I. H. Regulation of intracellular pH in eukaryotic cells. Biochem. J. 250, 1-8 (1988).
5. Hagag, N., Lacal, J. C., Graber, M., Aaronson, S. & Viola, M. V. Microinjection of ras p21 induces a rapid rise in intracellular pH. Mol. Cell. Biol. 7, 1984-1988 (1987). The first paper to show directly that microinjection of oncogenic RAS causes a rapid alkalinization of cells.
6. + antiporter in normal and transformed human lymphocytes and fibroblasts. Am. J. Physiol. 267, C745-C752 (1994).
7. 3 exchange in NIH-3T3 fibroblasts. J. Biol. Chem. 269, 4116-4124 (1994).
8. Ober, S. S. & Pardee, A. B. Intracellular pH is increased after transformation of Chinese hamster embryo fibroblasts. Proc. Natl Acad. Sci. USA 84, 2766-2770 (1987).
9. + exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation- associated phenotypes. FASEB J. 14, 2185-2197 (2000). This study showed that in HPV16E7-transformed cells, NHE1-dependent cellular alkalinization is an early event in neoplastic transformation that drives aerobic glycolysis, proliferation, serum- and anchorage-independent growth and formation of keratinocyte tumours in nude mice.
10. +-antiporter and mobilization of intracellular calcium. Adv. Enzyme Regul. 27, 121-131 (1988).
11. +-mediated unifying approach: pH-related and pH-unrelated mechanisms. Crit. Rev. Oncog. 6, 1-33 (1995).
12. Shrode, L. D., Tapper, H. & Grinstein, S. Role of intracellular pH in proliferation, transformation, and apoptosis. J. Bioenerg. Biomembr. 29, 393-399 (1997).
13. Juel, C. Lactate-proton cotransport in skeletal muscle. Physiol. Rev. 77, 321-358 (1997).
14. Gerweck, L. E. & Seetharaman, K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res. 56, 1194-1198 (1996).
15. Putney, L. K. & Barber, D. L. Expression profile of genes regulated by activity of the Na-H exchanger NHE1. BMC Genomics 5, 46 (2004).
16. Brand, K. A. & Hermfisse, U. Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J. 11, 388-395 (1997).
17. Doppler, W., Jaggi, R. & Groner, B. Induction of v-mos and activated Ha-ras oncogene expression in quiescent NIH 3T3 cells causes intracellular alkalinisation and cell-cycle progression. Gene 54, 147-153 (1987).
18. Pouyssegur, J., Franchi, A. & Pages, G. pHi, aerobic glycolysis and vascular endothelial growth factor in tumour growth. Novartis Found. Symp. 240, 186-196 (2001). A study showing that in vivo tumour growth is dependent primarily on NHE1.
19. Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364 (1996).
20. Bhujwalla, Z. M. et al. The physiological environment in cancer vascularization, invasion and metastasis. Novartis Found. Symp. 240, 23-38 (2001).
21. Gatenby, R. A. & Gillies, R. J. Why do cancers have high aerobic glycolysis? Nature Rev. Cancer 4, 891-899 (2004).
22. + exchange subtype 1 inhibition during extracellular acidification and hypoxia in glioma cells. J. Neurochem. 80, 36-44 (2002).
23. Yamagata, M., Hasuda, K., Stamato, T. & Tannock, I. F. The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. Br. J. Cancer 77, 1726-1731 (1998).
24. + exchange, motility, and invasion induced by serum deprivation. J. Biol. Chem. 275, 5361-5369 (2000). The first demonstration that tumour cell invasion requires NHE1 activity, and that serum deprivation stimulates NHE1 activity in tumour cells but not in normal cells.
25. + exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells. Breast Cancer Res. 6, R616-R628 (2004).
26. Cardone, R. A. et. al. Gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines. Mol. Biol. Cell 16, 3117-3127 (2005).
27. + exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J. Biol. Chem. 279, 26991-27007 (2004). Shows that ECM interaction with CD44 acidifies the microenvironment and promotes cell invasion, via stimulation of NHE1.
28. Chambers, A. F., Groom, A. C. & MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nature Rev. Cancer 2, 563-572 (2002).
29. Kerbel, R. S. Tumor angiogenesis: past, present and the near future. Carcinogenesis 21, 505-515 (2000).
30. + exchanger in cancer angiogenesis and antiangiogenesis. Br. J. Cancer 89, 1395-1399 (2003).
31. Kurschat, P. & Mauch, C. Mechanisms of metastasis. Clin. Exp. Dermatol. 25, 482-489 (2000).
32. Mareel, M. & Leroy, A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol. Rev. 83, 337-376 (2003).
33. Gatenby, R. A. & Gawlinski, E. T. A reaction-diffusion model of cancer invasion. Cancer Res. 56, 5745-5753 (1996).
34. 31P nuclear magnetic resonance study in vivo and in vitro. Magn. Reson. Med. 41, 897-903 (1999).
35. Vlodavsky, I. et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nature Med. 5, 793-802 (1999).
36. Kindzelskii, A. L. et al. Pericellular proteolysis by leukocytes and tumor cells on substrates: focal activation and the role of urokinase-type plasminogen activator. Histochem. Cell Biol. 121, 299-310 (2004).
37. Szpaderska, A. M. & Frankfater, A. An intracellular form of cathepsin B contributes to invasiveness in cancer. Cancer Res. 61, 3493-3500 (2001).
38. Tedone, T. et al. Release of the aspartyl protease cathepsin D is associated with and facilitates human breast cancer cell invasion. FASEB J. 11, 785-792 (1997).
39. Mook, O. R., Frederiks, W. M. & Van Noorden C. J. The role of gelatinases in colorectal cancer progression and metastasis. Biochim. Biophys. Acta. 1705, 69-89 (2004).
40. Bjorklund, M. & Koivunen, E. Gelatinase-mediated migration and invasion of cancer cells. Biochim. Biophys. Acta. 1755, 37-69 (2005).
41. Koblinski, J. E., Ahram, M. & Sloane, B. F. Unraveling the role of proteases in cancer. Clin. Chim. Acta. 291, 113-135 (2000).
42. Rozhin, J., Sameni, M., Ziegler, G. & Sloane, B. F. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res. 54, 6517-6525 (1994).
43. Kato, Y. et al. Acidic extracellular pH induces matrix metalloproteinase-9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signaling. J. Biol. Chem. 280, 10938-10944 (2005).
44. Glunde, K. et al. Extracellular acidification alters lysosomal trafficking in human breast cancer cells. Neoplasia 5, 533-545 (2003). Reports that reduced pHe stimulates both pseudopod formation and localized trafficking of lysosomes within the pseudopodia, creating a positive-feedback link between the processes of extracellular acidification, protease secretion and invasion.
45. Wolf, K. et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 160, 267-277 (2003). Describes the use of intravital multiphoton microscopy in cultured cells to study the association between secreted protease activity and cellular functional morphology.
46. Iwasaki, T. et al. Involvement of phosphorylation of Tyr-31 and Tyr-118 of paxillin in MM1 cancer cell migration, Int. J. Cancer 97, 330-335 (2002).
47. + exchanger NHE1. J. Cell Sci: 113, 3649-3662 (2000). The first study to demonstrate that transformation results in a dramatic remodelling of cellular morphology with a redistribution of NHE1 to the tip of the pseudopod, and that motility and transformed cell shape depend on NHE1 activity.
48. - exchangers in migrating renal epithelial cells. J. Gen. Physiol. 115, 599-608 (2000).
49. Sahai, E. & Marshall, C. J. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nature Cell Biol. 5, 711-719 (2003). Demonstrates that RHOA-ROCK1 signalling differs between cells that undergo mesenchymal and amoeboid dependent movement, and that cells with the mesenchymal cell shape are more invasive.
50. Friedl, P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr. Opin. Cell Biol. 16, 14-23 (2004).
51. Sahai, E. Mechanisms of cancer cell invasion. Curr. Opin. Genet. Dev. 15, 87-96 (2005). References 50 and 51 are recent reviews of invasive cell morphology.
52. 1 integrin and matrix metalloproteinases activity for migration and invasion. Lab. Invest. 81, 613-627 (2001).
53. Laudanna, C., Campbell, J. J. & Butcher, E. C. Elevation of intracellular cAMP inhibits RhoA activation and integrin-dependent leukocyte adhesion induced by chemoattractants. J. Biol. Chem. 272, 24141-24144 (1997).
54. Taguchi, A. et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405, 354-360 (2000).
55. Condeelis, J. & Segall, J. E. Intravital imaging of cell movement in tumours. Nature Rev. Cancer 3, 921-930 (2003).
56. Vadnais, J. et al. Autocrine activation of the hepatocyte growth factor receptor/met tyrosine kinase induces tumor cell motility by regulating pseudopodial protrusion. J. Biol. Chem. 277, 48342-48350 (2002).
57. 3,8-10 is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J. Cell. Physiol. 176, 206-215 (1998).
58. + exchange. J. Physiol. 567, 225-238 (2005).
59. Denker, S. P. & Barber, D. L. Cell migration requires both ion translocation and cytoskeletal anchoring by the Na-H exchanger NHE1. J. Cell Biol. 159, 1087-1096 (2002).
60. Patel, H. & Barber, D. L. A developmentally regulated Na-H exchanger in Dictyostelium discoideum is necessary for cell polarity during chemotaxis. J. Cell Biol. 169, 321-329 (2005).
61. Buccione, R., Orth, J. D. & McNiven, M. A. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nature Rev. Mol. Cell Biol. 5, 647-657 (2004). A recent review of invadopodia structure and function.
62. Kajiya, H., Okamoto, F., Fukushima, H. & Okabe, K. Calcitonin inhibits proton extrusion in resorbing rat osteoclasts via protein kinase A. Pflugers Arch. 445, 651-658 (2003).
63. + exchanger, NHE1: structure, regulation, and cellular actions. Annu. Rev. Pharmacol. Toxicol. 42, 527-552 (2002).
64. + exchanger NHE1 as plasma membrane scaffold in the assembly of signaling complexes. Am. J. Physiol. Cell Physiol. 287, C844-C850 (2004). Describes a scaffolding function for NHE1.
65. Orlowski, J. & Grinstein, S. Diversity of the mammalian sodium/proton exchanger SLC9 gene family. Pflugers Arch. 447, 549-565 (2004).
66. De Wever, O. et al. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J. 18, 1016-1018 (2004).
67. Bourguignon, L. Y., Zhu, H., Shao, L. & Chen, Y. W. CD44 interaction with Tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. J. Biol. Chem. 275, 1829-1838 (2000).
68. Bourguignon, L. Y., Singleton, P. A., Zhu, H. & Diedrich, F. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. J. Biol. Chem. 278, 29420-29434 (2003).
69. Shrode, L. D., Rubie, E. A., Woodgett, J. R. & Grinstein, S. Cytosolic alkalinization increases stress-activated protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK) activity and p38 mitogen-activated protein kinase activity by a calcium-independent mechanism. J. Biol. Chem. 272, 13653-13659 (1997).
70. Tominaga, T., Ishizaki, T., Narumiya, S. & Barber, D. L. p160ROCK mediates RhoA activation of Na-H exchange. EMBO J. 17, 4712-4722 (1998).
71. Hunter, K. W. Ezrin, a key component in tumor metastasis. Trends Mol. Med. 10, 201-204 (2004).
72. Pawson, T. & Scott, J. D. Signaling through scaffold, anchoring, and adaptor proteins. Science 278, 2075-2080 (1997).
73. Wahl, M. L. et al. Regulation of intracellular pH in human melanoma: potential therapeutic implications. Mol. Cancer Ther. 1, 617-628 (2002).
74. Izumi, H. et al. Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat. Rev. 29, 541-549 (2003).
75. Kuin, A. et al. Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG). Br. J. Cancer 79, 793-801 (1999).
76. Gatenby, R. A. et al. The possible role of postoperative azotemia in enhanced survival of patients with metastatic renal cancer after cytoreductive nephrectomy. Cancer Res. 62, 5218-5222 (2002).
77. Karmazyn, M. Role of sodium-hydrogen exchange in cardiac hypertrophy and heart failure: a novel and promising therapeutic target. Basic Res. Cardiol. 96, 325-328 (2001).